List of Tables
Table 1. Global Montelukast Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Montelukast Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Montelukast Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Montelukast Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Montelukast Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Montelukast Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Montelukast Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Montelukast Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Montelukast Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Montelukast Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Montelukast Drug, Product Type & Application
Table 12. Global Key Manufacturers of Montelukast Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Montelukast Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Montelukast Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Montelukast Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Montelukast Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Montelukast Drug Sales Market Share by Region (2020-2025)
Table 19. Global Montelukast Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Montelukast Drug Sales Market Share by Region (2026-2031)
Table 21. Global Montelukast Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Montelukast Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Montelukast Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Montelukast Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Montelukast Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Montelukast Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Montelukast Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Montelukast Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Montelukast Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Montelukast Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Montelukast Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Montelukast Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Montelukast Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Montelukast Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Montelukast Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Montelukast Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Montelukast Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Montelukast Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Montelukast Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Montelukast Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Montelukast Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Montelukast Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Montelukast Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Montelukast Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Montelukast Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Montelukast Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Montelukast Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Montelukast Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Montelukast Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Montelukast Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Montelukast Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Montelukast Drug Sales Market Share by Type (2020-2025)
Table 53. Global Montelukast Drug Sales Market Share by Type (2026-2031)
Table 54. Global Montelukast Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Montelukast Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Montelukast Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Montelukast Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Montelukast Drug Price (USD/Unit) by Type (2020-2025)
Table 59. Global Montelukast Drug Price (USD/Unit) by Type (2026-2031)
Table 60. Global Montelukast Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Montelukast Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Montelukast Drug Sales Market Share by Application (2020-2025)
Table 63. Global Montelukast Drug Sales Market Share by Application (2026-2031)
Table 64. Global Montelukast Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Montelukast Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Montelukast Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Montelukast Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Montelukast Drug Price (USD/Unit) by Application (2020-2025)
Table 69. Global Montelukast Drug Price (USD/Unit) by Application (2026-2031)
Table 70. Merck & Co. Company Information
Table 71. Merck & Co. Description and Business Overview
Table 72. Merck & Co. Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Merck & Co. Montelukast Drug Product
Table 74. Merck & Co. Recent Developments/Updates
Table 75. Teva Company Information
Table 76. Teva Description and Business Overview
Table 77. Teva Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Teva Montelukast Drug Product
Table 79. Teva Recent Developments/Updates
Table 80. Mylan Company Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Mylan Montelukast Drug Product
Table 84. Mylan Recent Developments/Updates
Table 85. Glenmark Pharmaceuticals Company Information
Table 86. Glenmark Pharmaceuticals Description and Business Overview
Table 87. Glenmark Pharmaceuticals Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Glenmark Pharmaceuticals Montelukast Drug Product
Table 89. Glenmark Pharmaceuticals Recent Developments/Updates
Table 90. Hikma Group Company Information
Table 91. Hikma Group Description and Business Overview
Table 92. Hikma Group Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Hikma Group Montelukast Drug Product
Table 94. Hikma Group Recent Developments/Updates
Table 95. Sandoz Company Information
Table 96. Sandoz Description and Business Overview
Table 97. Sandoz Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Sandoz Montelukast Drug Product
Table 99. Sandoz Recent Developments/Updates
Table 100. Torrent Pharmaceuticals Company Information
Table 101. Torrent Pharmaceuticals Description and Business Overview
Table 102. Torrent Pharmaceuticals Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Torrent Pharmaceuticals Montelukast Drug Product
Table 104. Torrent Pharmaceuticals Recent Developments/Updates
Table 105. Lannett Company Company Information
Table 106. Lannett Company Description and Business Overview
Table 107. Lannett Company Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Lannett Company Montelukast Drug Product
Table 109. Lannett Company Recent Developments/Updates
Table 110. Apotex Company Information
Table 111. Apotex Description and Business Overview
Table 112. Apotex Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Apotex Montelukast Drug Product
Table 114. Apotex Recent Developments/Updates
Table 115. Dr. Reddys Laboratories Company Information
Table 116. Dr. Reddys Laboratories Description and Business Overview
Table 117. Dr. Reddys Laboratories Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Dr. Reddys Laboratories Montelukast Drug Product
Table 119. Dr. Reddys Laboratories Recent Developments/Updates
Table 120. Aurobindo Pharma Company Information
Table 121. Aurobindo Pharma Description and Business Overview
Table 122. Aurobindo Pharma Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Aurobindo Pharma Montelukast Drug Product
Table 124. Aurobindo Pharma Recent Developments/Updates
Table 125. Accord Healthcare Company Information
Table 126. Accord Healthcare Description and Business Overview
Table 127. Accord Healthcare Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Accord Healthcare Montelukast Drug Product
Table 129. Accord Healthcare Recent Developments/Updates
Table 130. Hetero Company Information
Table 131. Hetero Description and Business Overview
Table 132. Hetero Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Hetero Montelukast Drug Product
Table 134. Hetero Recent Developments/Updates
Table 135. Unimark Company Information
Table 136. Unimark Description and Business Overview
Table 137. Unimark Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Unimark Montelukast Drug Product
Table 139. Unimark Recent Developments/Updates
Table 140. Ajanta Pharma Company Information
Table 141. Ajanta Pharma Description and Business Overview
Table 142. Ajanta Pharma Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Ajanta Pharma Montelukast Drug Product
Table 144. Ajanta Pharma Recent Developments/Updates
Table 145. MACLEODS Company Information
Table 146. MACLEODS Description and Business Overview
Table 147. MACLEODS Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. MACLEODS Montelukast Drug Product
Table 149. MACLEODS Recent Developments/Updates
Table 150. Jubilant Pharma Company Information
Table 151. Jubilant Pharma Description and Business Overview
Table 152. Jubilant Pharma Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Jubilant Pharma Montelukast Drug Product
Table 154. Jubilant Pharma Recent Developments/Updates
Table 155. Unichem Laboratories Company Information
Table 156. Unichem Laboratories Description and Business Overview
Table 157. Unichem Laboratories Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Unichem Laboratories Montelukast Drug Product
Table 159. Unichem Laboratories Recent Developments/Updates
Table 160. Amneal Pharmaceuticals Company Information
Table 161. Amneal Pharmaceuticals Description and Business Overview
Table 162. Amneal Pharmaceuticals Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Amneal Pharmaceuticals Montelukast Drug Product
Table 164. Amneal Pharmaceuticals Recent Developments/Updates
Table 165. Shanghai Anbison Lab Company Information
Table 166. Shanghai Anbison Lab Description and Business Overview
Table 167. Shanghai Anbison Lab Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. Shanghai Anbison Lab Montelukast Drug Product
Table 169. Shanghai Anbison Lab Recent Developments/Updates
Table 170. Perrigo Company Information
Table 171. Perrigo Description and Business Overview
Table 172. Perrigo Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 173. Perrigo Montelukast Drug Product
Table 174. Perrigo Recent Developments/Updates
Table 175. Cipla Company Information
Table 176. Cipla Description and Business Overview
Table 177. Cipla Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 178. Cipla Montelukast Drug Product
Table 179. Cipla Recent Developments/Updates
Table 180. CSPC Ouyi Pharmaceutical Company Information
Table 181. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 182. CSPC Ouyi Pharmaceutical Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 183. CSPC Ouyi Pharmaceutical Montelukast Drug Product
Table 184. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Montelukast Drug Distributors List
Table 188. Montelukast Drug Customers List
Table 189. Montelukast Drug Market Trends
Table 190. Montelukast Drug Market Drivers
Table 191. Montelukast Drug Market Challenges
Table 192. Montelukast Drug Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
Table 196. Authors List of This Report
List of Figures
Figure 1. Product Picture of Montelukast Drug
Figure 2. Global Montelukast Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Montelukast Drug Market Share by Type: 2024 & 2031
Figure 4. Tablets Product Picture
Figure 5. Oral Granules Product Picture
Figure 6. Global Montelukast Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Montelukast Drug Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Others
Figure 11. Global Montelukast Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Montelukast Drug Market Size (2020-2031) & (US$ Million)
Figure 13. Global Montelukast Drug Sales (2020-2031) & (K Units)
Figure 14. Global Montelukast Drug Average Price (USD/Unit) & (2020-2031)
Figure 15. Montelukast Drug Report Years Considered
Figure 16. Montelukast Drug Sales Share by Manufacturers in 2024
Figure 17. Global Montelukast Drug Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Montelukast Drug Players: Market Share by Revenue in Montelukast Drug in 2024
Figure 19. Montelukast Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Montelukast Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Montelukast Drug Sales Market Share by Country (2020-2031)
Figure 22. North America Montelukast Drug Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Montelukast Drug Sales Market Share by Country (2020-2031)
Figure 26. Europe Montelukast Drug Revenue Market Share by Country (2020-2031)
Figure 27. Germany Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Montelukast Drug Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Montelukast Drug Revenue Market Share by Region (2020-2031)
Figure 34. China Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Montelukast Drug Sales Market Share by Country (2020-2031)
Figure 45. Latin America Montelukast Drug Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Montelukast Drug Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Montelukast Drug Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Montelukast Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Montelukast Drug by Type (2020-2031)
Figure 55. Global Revenue Market Share of Montelukast Drug by Type (2020-2031)
Figure 56. Global Montelukast Drug Price (USD/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Montelukast Drug by Application (2020-2031)
Figure 58. Global Revenue Market Share of Montelukast Drug by Application (2020-2031)
Figure 59. Global Montelukast Drug Price (USD/Unit) by Application (2020-2031)
Figure 60. Montelukast Drug Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
